Ask AI
ProCE Banner Activity

Are You Starting From the Top in IBD? New Guideline Recommendations in IBD Treatment Selection

Clinical Thought

Learn how the latest guideline updates are changing the inflammatory bowel disease (IBD) landscape and what healthcare professionals need to know when addressing persistent challenges in ensuring positive outcomes for patients with IBD.

Released: April 21, 2026

Continue Activity View Activity

Share

Provided by

Provided by Clinical Care Options, LLC dba Decera Clinical Education, in partnership with Smart Patients.

ProCE Banner

Supporters

Supported by an independent educational grant from AbbVie.

AbbVie

Partners

Smart Patients

ProCE Banner

Target Audience

This activity is intended for gastroenterologists, nurse practitioners (NPs), physician associates (PAs), and other HCPs who manage patients with IBD.

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Formulate personalized IBD treatment plans in alignment with the latest guidelines, recent evidence, and patient preferences

Disclosure

Primary Author

Jessica Allegretti, MD, MPH, FACG, AGAF: consultant/advisor/speaker: AbbVie, Celltrion, Curogen, Ferring, Genentech, GSK, Janssen, MetaGen, Pfizer, Shattuck Labs, TRexBio, Vedanta, Xencor.